Tonghua Dongbao Pharmaceutical Co., Ltd. Class ASSE: 600867

Announcement on SSE’s Reply to Letter of Supervision and Inquiry on Information Disclosure of 2024 Annual Report

· Issued by Tonghua Dongbao Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on SSE’s Reply to Letter of Supervision and Inquiry on Information Disclosure of 2024 Annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis